Onkologie, Hämatologie - Daten und Informationen

Literatur zu Kapitel 8.7: Palliativmedizinische Betreuung

Autor/en: U. Schuler, B. Schubert, A. Reichle
Letzte Änderung: 01.07.2008
  • Back AL et al.
    Approaching difficult communication tasks in oncology.
    CA Cancer J Clin 2005;55(3):164-177.

  • Burnett AK et al.
    A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.
    Cancer 2007;109(6):1114-1124.

  • Christopher KA.
    The experience of donating bone marrow to a relative.
    Oncol Nurs Forum 2000;27(4):693-700.

  • Couriel D et al.
    Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.
    Biol Blood Marrow Transplant 2006;12(4):375-396.

  • Denzlinger C et al.
    Low-dose melphalan induces favourable responses in elderly patients with high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia.
    Br J Haematol 2000;108(1):93-95.

  • Funke I et al.
    Palliative cytoreduction in refractory acute leukemia: a retrospective study of 57 adult patients.
    Ann Hematol 2000;79(3):132-137.

  • Gratwohl A et al.
    Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time.
    Bone Marrow Transplant 2005;36(9):757-769.

  • Kappauf HW.
    Kommunikation in der Onkologie.
    Hautarzt 2004;55(8):709-714.

  • Kleeberg UR et al.
    Patient satisfaction and quality of life in cancer outpatients: results of the PASQOC study.
    Support Care Cancer 2005;13(5):303-310.

  • Lautrette A et al.
    End-of-life family conferences: rooted in the evidence.
    Crit Care Med 2006;34(11 Suppl):364-372.

  • Lautrette A et al.
    A communication strategy and brochure for relatives of patients dying in the ICU.
    N Engl J Med 2007;356(5):469-478.

  • McGrath P.
    End-of-life care for hematological malignancies: the “technological imperative” and palliative care.
    J Palliat Care 2002;18(1):39-47.

  • Navigante AH et al.
    Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.
    J Pain Symptom Manage 2006;31(1):38-47.

  • Rassin M et al.
    Caregivers' role in breaking bad news: patients, doctors, and nurses' points of view.
    Cancer Nurs 2006;29(4):302-308.

  • Shirai Y et al.
    Nurses' perception of adequacy of care for leukemia patients with distress during the incurable phase and related factors.
    Leuk Res 2005;29(3):293-300.

  • Shpilberg O et al.
    A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia.
    Leuk Lymphoma 1995;19(1-2):141-144.

  • Stalfelt AM et al.
    The final phase in acute myeloid leukaemia (AML): a study of cause of death, place of death and type of care during the last week of life.
    Leuk Res 2001;25(8):673-680.

  • Stalfelt AM et al.
    The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain.
    Leuk Res 2003;27(6):481-488.

  • Switzer GE et al.
    The effects of bereavement on adult sibling bone marrow donors' psychological well-being and reactions to donation.
    Bone Marrow Transplant 1998;21(2):181-188.

Bei ONKODIN publiziert in Kooperation mit "Deutscher Ärzte-Verlag" (Publikation als Buch)
Deutscher Ärzte-Verlag  Deutscher Ärzte-Verlag
und in Kooperation mit "Studien-Allianz Leukämie"
Deutscher Ärzte-Verlag  Studien-Allianz Leukämien
Aktuelle Berichte vom 58th
ASH Annual Meeting 2016,
San Diego, Kalifornien, USA [Mehr]
2016 ASCO Annual Meeting - aktuelle Berichte. Dieser Service wird gefördert durch: